HIV-1 diversity in Romania.
Cristian Apetrei(University of Pittsburgh), François Simon(Université Claude Bernard Lyon 1), G Molnár(Ministerul Sanatatii), M Duca(Grigore T. Popa University of Medicine and Pharmacy), Adrian Streinu‐Cercel(Carol Davila University of Medicine and Pharmacy), E Neguţ(Institutul Cantacuzino), Ivona Pandrea(University of Pittsburgh), Carol Holm‐Hansen, Carmen Cozmei(Institute of Medical Microbiology and Hygiene), Flavia Rodica Pascu, Ibtissam Loussert-Ajaka(Université Claude Bernard Lyon 1), Françoise Brun‐Vézinet(Université Claude Bernard Lyon 1), Adriana Necula(National Blood Transfusion Service), M Pecec(National Blood Transfusion Service)
PubMed
June 18, 1998
Cited by 51
Related Papers
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208
Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)
|Hepatology|2014|165
Lymphadenopathy-Associated Viral Antibody in AIDS
|New England Journal of Medicine|1984|123
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection
|Gastroenterology|2020|116
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
|Clinical Gastroenterology and Hepatology|2019|111